Ameriprise Financial Inc Infinity Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.14 - $0.24 $238 - $408	-1,700 Reduced 10.76%	14,100 $2,000
Q1 2023 May 15, 2023	SELL	$0.16 - $0.74 $4,800 - $22,200	-30,000 Reduced 65.5%	15,800 $2,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $1.21 $8,243 - $21,683	-17,920 Reduced 28.12%	45,800 $25,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $3,068 - $8,840	-5,200 Reduced 7.54%	63,720 $76,000
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $3,177 - $7,782	-6,485 Reduced 8.6%	68,920 $44,000
Q1 2022 May 16, 2022	SELL	$0.85 - $2.4 $1,181 - $3,336	-1,390 Reduced 1.81%	75,405 $86,000
Q4 2021 Feb 14, 2022	SELL	$1.86 - $3.36 $98,775 - $178,432	-53,105 Reduced 40.88%	76,795 $173,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $45,600 - $114,600	30,000 Added 30.03%	129,900 $444,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $19,418 - $25,331	7,300 Added 7.88%	99,900 $299,000
Q1 2021 May 17, 2021	BUY	$1.98 - $5.36 $150,876 - $408,432	76,200 Added 464.63%	92,600 $299,000
Q2 2020 Aug 14, 2020	BUY	$0.77 - $1.13 $1,771 - $2,598	2,300 Added 16.31%	16,400 $15,000
Q1 2020 May 15, 2020	BUY	$0.69 - $1.52 $9,729 - $21,432	14,100 New	14,100 $12,000
Q2 2018 Aug 14, 2018	SELL	$1.72 - $2.26 $134,538 - $176,777	-78,220 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $18 - $27	10 Added 0.01%	78,220 $164,000
Q4 2017 Feb 12, 2018	SELL	$1.22 - $3.73 $976 - $2,984	-800 Reduced 1.01%	78,210 $159,000
Q3 2017 Nov 07, 2017	BUY	$0.94 - $1.35 $74,269 - $106,663	79,010	79,010 $105,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.